Actualités 29. Jan. 2024 L’innovateur en bioproduction Stämm ouvre son centre européen de R&D à Monthey Stämm, une entreprise leader en matière d’innovation dans les technologies de bioprocédés, a annoncé l’ouverture de son nouveau centre de R&D au ...
News 29. Jan. 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 18. Dez. 2023 UPM Biomedicals chooses the Basel Area as European bridgehead UPM Biomedicals is opening a lab on the Main Campus of Switzerland Innovation Park Basel Area. The Finnish company specializes in nanofibrillar c...
Novità 02. Juni 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...
Aktuell 27. März 2024 TissueLabs startet Biofabrikation in Bellinzona TissueLabs sichert sich 800'000 Dollar und eröffnet ein neues Zentrum für Biofabrikation in Bellinzona. Die Mittel dienen der Verbesserung der ei...
News 27. März 2024 TissueLabs begins biofabrication activities in Bellinzona TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh ...
Actualités 02. Juni 2023 UNE ÉTUDE RÉCENTE MONTRE QUE 20 % DES SOCIÉTÉS DE BIOTECHNOLOGIE EUROPÉENNES ONT DÉSORMAIS LEUR SIÈGE EN SUISSE Press release Une nouvelle étude menée par IQVIA et récemment publiée dans le Swiss Biotech Report 2023 montre que 20 % des sociétés de biotechnologie eur...
News 24. Mai 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Actualités 29. Febr. 2024 Les Grands Titres de Suisse occidentale (Février 2024) D’importantes avancées en matière de semi-conducteurs et de percées dans la recherche médicale à des avancées stratégiques dans les secteurs de l...
Actualités 30. Jan. 2024 Les Grands Titres de Suisse occidentale (Janvier 2024) Des avancées révolutionnaires dans l’agroalimentaire et la robotique aux réformes économiques stratégiques en passant par la recherche pionnière ...
News 30. Jan. 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
News 29. Febr. 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Aktuell 22. Jan. 2024 DISCO Pharmaceuticals startet mit 20 Millionen Euro Kapital DISCO Pharmaceuticals ist mit einem Startkapital von 20 Millionen Euro neu auf dem Markt. Sein Team hat als erstes eine Methode entwickelt, die e...
News 22. Jan. 2024 DISCO Pharmaceuticals secures seed funding of 20 million euros DISCO Pharmaceuticals has secured seed funding of 20 million euros and officially launched the business. The team was the first to develop a meth...
News 20. Mai 2022 BeiGene opens European headquarters in Basel BeiGene has opened its new European headquarters in Basel. The global biotech company specializing in innovative cancer treatments intends to bui...
Aktuell 10. Jan. 2024 Noor Biotech wählt Basel als Standort Die Firma Noor Biotech hat sich in Basel gegründet. Das Start-up unter der Leitung der saudi-arabischen Mitgründerin Nuha Alekhmini entwickelt ei...
News 10. Jan. 2024 Noor Biotech opts to establish location in Basel Noor Biotech has established a presence in Basel. The start-up, which is managed by its Saudi Arabian co-founder Nuha Alekhmini, is developing a ...
뉴스 02. Juni 2023 최신 연구에 따르면 유럽 바이오테크 기업의 20%가 스위스에 본사를 두고 있습니다 Press release IQVIA가 수행하고 최근 2023 스위스 바이오테크 보고서에 발표된 새로운 연구에 따르면 유럽 바이오테크 기업의 20%가 현재 스위스에 본사를 두고 있습니다. 또한 스위스 연방 정부, 주 및 지역의 작년 투자 유치 통계에 따르면 이러한 추세가 지속되고 있음을...